Trials / Completed
CompletedNCT02305043
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Adenocarcinoma of the Stomach or Gastroesophageal Junction. A Non-interventional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 549 (actual)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to identify biomarkers predicting response or resistance factors of a targeted therapy with trastuzumab in advanced gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | non-interventional | non-interventional |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-31
- First posted
- 2014-12-02
- Last updated
- 2018-07-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02305043. Inclusion in this directory is not an endorsement.